Light-induced toxic effects of tamoxifen: A chemotherapeutic and chemopreventive agent

Journal of Photochemistry and Photobiology A: Chemistry

Volumn 201, Issue 1, 2009, Pages 50-56

  Wang, Shuguang ^a   Wang, Lei ^a   Yin, Jun Jie ^b   Wang, Zheng ^a   Fu, Peter P ^c   Yu, Hongtao ^a  

^a JACKSON STATE UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

DNA damage; HaCaT keratinocytes; Lipid peroxidation; Phototoxicity; Salmonella TA102; Tamoxifen

Indexed keywords

EID: 57749201810     PISSN: 10106030     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotochem.2008.09.013     Document Type: Article

References (55)

1. Harwood K.V. Advances in endocrine therapy for breast cancer: considering efficacy, safety, and quality of life. Clin. J. Oncol. 8 (2004) 629-637
2. Shibutani S., Ravindernath A., Suzuki M., Terashima I., Sugarman S.M., Grollman A.P., and Paearl M.L. Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen. Carcinogenesis 21 (2000) 1461-1467
3. Shibutani S., Reardon J.T., Suzuki M., and Sancar A. Excision of tamoxifen-DNA adducts by the human nucleotide excision repair system. Cancer Res. 60 (2000) 2607-2610
4. Glatt H., Davis W., Meinl W., Hermersdörfer H., Venitt S., and Phillips D.H. Rat, but not human, sulfotransferase activates a tamoxifen metabolite to prodice DNA adducts and gene mutations in bacteria and mammalian cells in culture. Carcinogenesis 19 (1998) 1709-1713
5. 32P-postlabeling. Cancer Res. 59 (1999) 4829-4833
6. Hellmann-Blumberg U., Cartner M.G., Wurz G.T., and DeGregorio M.W. Intrinsic reactivity of tamoxifen and toremifene metabolites with DNA. Breast Cancer Res. Treat. 50 (1998) 135-141
7. Rajaniemi H., Koskinen M., Mantuyla E., and Hemminski K. DNA binding of tamoxifen and its analogues: Identification of the tamoxifen-DNA adducts in rat liver. Toxicol. Lett. 102-103 (1998) 453-457
8. McLuckie K.I.E., Routledge M.N., Brown K., Gaskell M., Farmer P.B., Roberts G.C.K., and Martin E.A. DNA adducts formed from 4-hydroxytamoxifen are more mutagenic than those formed by α-acetoxytamoxifen in a shuttle vector target gene replicated in human AD293 cells. Biochemistry 41 (2002) 8899-8906
9. M.I. Willems, J. van Benthem, National Institute of Public Health and the Environment (RIVM) Bilthoven, Netherlands Organization for Applied for Scientific Research (TNO) Zeist, AI Zeist, The Netherlands, 2000, pp. 1-47.
10. Davies R., Gant T.W., Smoith L.L., and Styles J.A. Tamoxifen induces G:C→T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5′-CpG-3′ dinucleotide sequences as found in the lacI transgene. Carcinogenesis 20 (1999) 1351-1356
11. Styles J.A., Davies R., Fenwick S., Walker J., White I.N.H., and Smith L.L. Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion. Cancer Lett. 162 (2001) 117-122
12. Gupta S., Mukhopadhyay A., Ray S., and Giri A.K. Comparative antimutagenic effects of d- and l-centchroman and their comparison with tamoxifen in Salmonella assay. Mutat. Res. 445 (1999) 1-8
13. Yu H. Environmental carcinogenic polycyclic aromatic hydrocarbons: photochemistry and phototoxicity. J. Environ. Sci. Health, Part C-Environ. Carcinog. Ecotoxic. Rev. C20 (2002) 149-183
14. Onoue S., and Tsuda Y. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharm. Res. 23 (2006) 156-164
15. DellaGreca M., Iesce M.R., Isidori M., Nardelli A., Previtera L., and Rubino M. Phototransformation products of tamoxifen by sunlight in water. Toxicity of the drug and its derivatives on aquatic organisms. Chemosphere 67 (2007) 1933-1939
16. Salamoun J., Macka M., Nechvatal M., Matousek M., and Knesel L. Identification of products formed during UV irradiation of tamoxifen and their use for fluorescence detection in high-performance liquid chromatography. J. Chromatogr. 514 (1990) 179-187
17. Campeta A.M., Lombardo F., Sharp T.S., Horan G.J., and Rescek D.M. Identification of photodegradants of droloxifene by combined HPLC-MS, NMR spectroscopy and computational chemistry. J. Phys. Org. Chem. 12 (1999) 881-889
18. Wilson S., and Ruenitz P.C. Structural characterization and biological effects of photocyclized products of tamoxifen irradiation. J. Pharm. Sci. 82 (1993) 571-574
19. Tajima M., Saito M., Kato Y., Oh-I T., and Tsuboi R. A case of male breast cancer involving a photosensitive reaction induced by doxifluridine. Nishinihon J. Dertmat. 67 (2005) 475-477
20. Bostrom A., Sjolin-Forsberg G., Wilking N., and Bergh J. Radiation recall: another call with tamoxifen. Acta Oncol. 38 (1999) 955-959
21. Jhaveri K., Halperin P., and Shin S.J. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature. Breast Cancer Res. Treat. 106 (2007) 315-318
22. Janzen E.G., and Hare D.L. Two decades of spin trapping. Adv. Radic. Chem. 1 (1990) 253
23. Rinalducci S., Pedersen J.Z., and Zolla L. Formation of radical from signet oxygen produced during photoinhibition of isolated light-harvesting protein of photosystem II. Biochim. Biophys. Acta 1608 (2004) 63-73
24. Zhao H., Joseph J., Zhang H., Karoui H., and Kalyanaraman B. Synthesis and biochemical applications of a solid cyclic nitrone spin trap: a relatively superior trap for detecting superoxide anions and glutathiyl radicals. Free Rad. Biol. Med. 31 (2001) 599-606
25. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
26. Wang L., Yan J., Fu P.P., Parekh K.A., and Yu H. Photomutagenicity of cosmetic ingredient chemicals azulene and guaiazulene. Mutat. Res. 530 (2003) 19-26
27. Yan J., Wang L., Fu P.P., and Yu H. Photomutagenicity of 16 polycyclic aromatic hydrocarbons from the US EPA priority pollutant list. Mutat. Res. 557 (2004) 99-108
28. Ben-Hur E., Prager A., Green A.P., and Rosenthal I. pH dependence of the phototoxic and photomutagenic effects of chlorpromazine. Chem.-Biol. Interact. 29 (1980) 223-233
29. Wang L., Yan J., Hardy W., Mosley C., Wang S., and Yu H. Light-induced mutagenicity in Salmonella TA102 and genotoxicity/cytotoxicity in human T-cells by 3,3′-dichlorobenzidiine: a chemical used in the manufacture of dyes and pigments and in tattoo inks. Toxicology 207 (2005) 411-418
30. Zheng B., Hwang H.-M., Yu H., and Ekunwe S. DNA damage produced in HaCat cells by combined fluoranthenne exposure and ultraviolet A irradiation. Environ. Mol. Mutagen. 44 (2004) 151-155
31. Wang S., Sheng Y.H., Feng M., Leszczynski J., Wang L., Tachikawa H., and Yu H. Light-induced cytotoxicity of 16 polycyclic aromatic hydrocarbons on the US EPA priority pollutant list in human skin HaCaT keratinocytes: relationship between phototoxicity and excited state properties. Environ. Toxicol. 22 (2007) 318-327
32. Dong S., Fu P.P., Shirsat R.N., Hwang H.-M., Leszczynski J., and Yu H. UVA light-induced DNA cleavage by isomeric methybena[a]anthracenes. Chem. Res. Toxicol. 15 (2002) 400-407
33. Xia Q., Yin J.J., Cherng S.-H., Wamer W.G., Boudreau M., Howard P.C., and Fu P.P. UVA photodecomposition of retinyl palmitate-formation of singlet oxygen and superoxide, and their role in induction of lipid peroxidation. Toxicol. Lett. 163 (2006) 30-43
34. Takita M., and Marita M. Identification of new geometric isomers of methyl linoleate hydroperoxide and their chromatographic behavior. Biosci. Biotechnol. Biochem. 64 (2000) 1044-1046
35. Cherng S.-H., Xia Q., Blankenship L.R., Freeman J.P., Wamer W.G., Howard P.C., and Fu P.P. Photodecomposition of retinyl palmitate in ethanol by UVA light-formation of photodecomposition products, reactive oxygen species, and lipid peroxides. Chem. Res. Toxicol. 18 (2005) 129-138
36. Majumdar S.K., Valdellon J.A., and Brown K.A. In vitro investigations on the toxicity and cell death induced by tamoxifen on two non-breast cancer cell types. J. Biomed. Biotech. 1 (2001) 99-107
37. Dong S., Hwang H.-M., Shi X., Holloway L., and Yu H. UVA-induced DNA single-strand cleavage by 1-hydroxypyrene and formation of colvalent adducts between DNA and 1-hydroxypyrene. Chem. Res. Toxicol. 13 (2000) 585-593
38. Agon V.V., Bubb W.A., Wright A., Hawkins C.L., and Davies M.J. Sensitizer-mediated photooxidation of histidine residues: evidence for the formation of reactive side-chain peroxides. Free Rad. Biol. Med. 40 (2006) 698-710
39. Pazos M., Anderson M.L., and Skibsted L.H. Amino acid and protein scavenging of radicals generated by iron/hydrogenperoxide system: an electron spin resonance spin trapping study. J. Agr. Food Chem. 54 (2006) 10215-10221
40. Saeed S., Fawthrop S.A., and Howell N.K. Electron spin resonance (ESR) study on free radical transfer in fish lipid-protein interaction. J. Sci. Food Agr. 79 (1999) 1809-1816
41. Park J., Troxel A.B., Harvey R.G., and Penning T.M. Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the Aldo-keto-reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species. Chem. Res. Toxicol. 19 (2006) 719-728
42. Tanaka K., Tokumaru S., and Kojo S. Possible involvement of radical reactions in desialylation of LDL. FEBS Lett. 413 (1997) 202-204
43. Graham M.J., Freier S.M., Crooke R.M., Ecker D.J., Masslova R.N., and Lesnik E.A. Trtiium labeling of antisense oligonucleotides by exchange with tritiated water. Nucl. Acids Res. 21 (1993) 2737-3743
44. Evans E., Baskevitch P.P., and Rochefort H. Estrogen receptor-DNA interaction: differences between activation by estrogen and antiestrogen. Eur. J. Biochem. 128 (1982) 185-191
45. Snyder R.D., and Brown J.E. Evidence for and role of the dimethylamino group in tamoxifen DNA intercalation in intact Chinese Hamster V79 cells. Drug Chem. Toxicol. 25 (2002) 473-479
46. Wozniak K., Kolacinska A., Blasinska-Morawiec M., Morawiec-Bajda A., Morawiec Z., Zadrozny M., and Blasiak J. The DNA-damaging potential of tamoxifen in breast cancer. Arch. Toxicol. 81 (2007) 519-527
47. 2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen. Cancer Res. 59 (1999) 2091-2095
48. Kim S.Y., Suzuki N., Laxmi Y.R.S., McGarrigle B.P., Olson J.R., Sharma M., Sharma M., and Shibutani S. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to a-hydroxytamoxifen. Chem. Res. Toxicol. 18 (2005) 885-895
49. Umemoto A., Monden Y., Lin C., Momen M.A., Ueyama Y., Komaki K., Laxmi Y.R.S., and Shibutani S. Determination of tamoxifen-DNA adducts in leukocytes from breast cancer patients treated with tamoxifen. Chem. Res. Toxicol. 17 (2004) 1577-1583
50. Yu H., Yan J., Jiao Y., and Fu P. Photochemical reaction of 7,12-dimethylbenz[a]anthracene and formation of DNA covalent adducts. Int. J. Environ. Res. Public Health 2 (2005) 114-122
51. Jin Y., Desta Z., Stearns V., Ward B., Ho H., Lee K.-H., Skaar T., Storniolo A.M., Li L., Araba A., Blanchard R., Nguyen A., Ullmer L., Hayden J., Lemler S., Weinshilboum R.M., Rae J.M., Hayes D.F., and Flockhart D.A. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J. Nat. Cancer Inst. 97 (2005) 30-39
52. Decensi A., Gradini D., Guerrieri-Gonzaga A., Johansson H., Mananni B., Bonanni B., Sandri M.T., Barreca A., Costa A., Robertson C., and Lien E.A. Effects of blood tamoxifen concentrations on surrogate biomakers in a trial of dose reduction in healthy women. J. Clin. Oncol. 17 (1999) 2633-2638
53. Bergan R.C., Reed E., Myers C.E., Headlee D., Brawley O., Cho H.-K., Figg W.D., Tompkins A., Linehan W.M., Kohler D., Steinberg S.M., and Blagosklonny M.V. A phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. Clin. Cancer Res. 5 (1999) 2366-2373
54. Kisanga E.R., Gjerde J., Guerrieri-Gonzaga A., Pigatto F., Pesci-Feltri A., Robertson C., Serrano D., Pelosi G., Decensi A., and Lien E.A. Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clin. Cancer Res. 10 (2004) 2336-2343
55. Nieder M., and Jaeger H. Quantification of tamoxifen and N-desmethyltamoxifen in human plasma by high-performance liquid chromatography, photochemical reaction and fluorescence detection, and its application to biopharmaceutical investigation. J. Chromatogr. 413 (1987) 207-217